Dec 1 (Reuters) - Bionomics Ltd (BNO) : U.S. FDA GRANTED FAST TRACK DESIGNATION TO BNC210 DEVELOPMENT PROGRAM FOR ACUTE TREATMENT OF SOCIAL ANXIETY DISORDER